Tag: #M&A

Gilead Sciences Inc. and Lakefront Biotherapeutics NV have formally finalized the acquisition of Ouro Medicines to accelerate innovative T cell... Read more

U.S. pharmaceutical major Eli Lilly and Co. has entered into a definitive global licensing agreement with biotechnology firm Ascidian Therapeutics... Read more

Public equity markets logged a significant upward move for biotech developer Rallybio Corp., with its stock price hitting 24-month trading... Read more

U.S. pharmaceutical powerhouse Eli Lilly and Company and South Korea’s Hanmi Pharm have formalized a definitive licensing and commercialization agreement... Read more

U.S. biotech developer Edgewise Therapeutics has entered into a definitive agreement to sell its muscular dystrophy drug candidate and related... Read more

Medtech conglomerate Olympus Corporation has finalized a definitive agreement to acquire implantable technology innovator BioProtect for a total consideration of... Read more

Amid an intensive capital mobilization program driving next-generation weight-loss manufacturing expansions, global contract development and manufacturing organization (CDMO) CordenPharma has... Read more

Modern pharmacy retail chain Pharmacity has finalized a definitive funding round with international impact investor LeapFrog Investments, marking a new... Read more

U.S. pharmaceutical heavyweight Eli Lilly has announced definitive agreements to purchase three clinical-stage vaccine developers in multi-lateral transactions valued at... Read more